Explained — Why Granules India shares fell on Wednesday

Share it

The warning letter issued by the USFDA for Granules India’s Gagillapur unit highlights data integrity, quality and contamination issues and analysts do not expect a faster clearance for the plant.

Leave a Comment

Your email address will not be published. Required fields are marked *